Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
1.350
-0.060 (-4.26%)
At close: Feb 3, 2026, 4:00 PM EST
1.360
+0.010 (0.74%)
After-hours: Feb 3, 2026, 6:32 PM EST

Standard BioTools Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
51965117593300445
Market Cap Growth
-21.21%271.28%89.12%-69.06%-32.58%83.70%
Enterprise Value
352375458322376468
Last Close Price
1.351.752.211.173.926.00
PS Ratio
3.013.741.650.952.303.22
PB Ratio
1.301.381.080.403.173.20
P/TBV Ratio
1.301.97----
EV/Sales Ratio
2.072.154.303.292.883.39
Debt / Equity Ratio
0.070.070.600.451.180.69
Asset Turnover
0.280.370.300.290.440.47
Inventory Turnover
2.582.942.662.884.895.44
Quick Ratio
1.934.961.234.210.941.73
Current Ratio
4.385.701.454.811.452.17
Return on Equity (ROE)
-33.26%-43.75%-37.99%-117.21%-50.71%-36.23%
Return on Assets (ROA)
-14.55%-18.01%-11.05%-18.61%-14.06%-10.82%
Return on Capital Employed (ROCE)
-32.90%-24.70%-29.50%-28.60%-29.90%-18.90%
Earnings Yield
-24.70%-21.32%-42.55%-204.90%-19.76%-11.92%
FCF Yield
-18.96%-23.30%-26.28%-100.45%-19.12%-6.33%
Buyback Yield / Dilution
-35.61%-346.24%-1.09%-3.32%-5.19%-7.88%
Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q